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Abstract Multiple epiphyseal dysplasia (MED) can result
from mutations in matrilin-3, a structural protein of the
cartilage extracellular matrix. We have previously shown
that in a mouse model of MED the tibia growth plates were
normal at birth but developed a progressive dysplasia
characterised by the intracellular retention of mutant
matrilin-3 and abnormal chondrocyte morphology. By
3 weeks of age, mutant mice displayed a significant
decrease in chondrocyte proliferation and dysregulated
apoptosis. The aim of this current study was to identify
the initial post-natal stages of the disease. We confirmed
that the disease phenotype is seen in rib and xiphoid
cartilage and, like tibia growth plate cartilage is charac-
terised by the intracellular retention of mutant matrilin-3.
Gene expression profiling showed a significant activation
of classical unfolded protein response (UPR) genes in
mutant chondrocytes at 5 days of age, which was still
maintained by 21 days of age. Interestingly, we also noted
the upregulation of arginine-rich, mutated in early stage of
tumours (ARMET) and cysteine-rich with EGF-like domain
protein 2 (CRELD2) are two genes that have only recently
been implicated in the UPR. This endoplasmic reticulum
(ER) stress and UPR did not lead to increased chondro-
cyte apoptosis in mutant cartilage by 5 days of age. In an
attempt to alleviate ER stress, mutant mice were fed with
a chemical chaperone, 4-sodium phenylbutyrate (SPB).
SPB at the dosage used had no effect on chaperone
expression at 5 days of age but modestly decreased levels
of chaperone proteins at 3 weeks. However, this did not
lead to increased secretion of mutant matrilin-3 and in the
long term did not improve the disease phenotype. We
performed similar studies with a mouse model of Schmid
metaphyseal chondrodysplasia, but again this treatment
did not improve the phenotype.
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Introduction
The rough endoplasmic reticulum (rER) has stringent
quality control mechanisms to ensure that only properly
folded proteins are allowed to leave the rER, thus mediating
the secretion of high-quality functional proteins (Kaufman
1999, 2002; Rutkowski and Kaufman 2004). Correctly
folded proteins are translocated to the Golgi apparatus
where they undergo additional processing before trafficking
to their intended destinations, either secretion into the
extracellular matrix (ECM) or embedding in the plasma
membrane or to the lysosome.
A number of protein folding disorders result from the
accumulation of unfolded or misfolded proteins within the
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DOI 10.1007/s12192-010-0193-yrER, causing ER stress (Kaufman 2002). This ER stress
can lead to an upregulation of many rER resident proteins
involved in protein folding to protect the cells from the ER
stress and is known as an unfolded protein response (UPR).
The chondrodysplasias are a clinically and genetically
heterogeneous group of over 200 unique phenotypes that
effect the development of the osseous skeleton (Hall 2002).
Numerous chondrodysplasias can result from mutations in
the genes encoding cartilage extracellular matrix proteins
(Superti-Furga et al. 2001) that can sometimes lead to
misfolding and an accumulation of mutant protein within
the rER (Bateman et al. 2009; Boot-Handford and Briggs
2009). Mutant protein accumulation in the rER is a key
pathological feature in a range of different mouse models of
chondrodysplasias, primary amongst which are models of
pseudoachondroplasia, multiple epiphyseal dysplasia
(Leighton et al. 2007; Schmitz et al. 2008) and metaphyseal
chondrodysplasia type Schmid (MCDS; Ho et al. 2007;
Rajpar et al. 2009; Tsang et al. 2007).
Multiple epiphyseal dysplasia (MED) is a clinically
variable and genetically heterogeneous chondrodysplasia that
is characterised by mild short stature, joint pain and stiffness
and early onset osteoarthritis. Autosomal-dominant forms of
MED can result from mutations in the genes encoding three
cartilage structural proteins, cartilage oligomeric matrix
protein,typeIXcollagenandmatrilin-3(BriggsandChapman
2002). Matrilin-3 is the third member of a family of four
ECM proteins; matrilin-1 and matrilin-3 are primarily
expressed in cartilage, whilst matrilin-2 and matrilin-4 have
a wider pattern of expression in a variety of ECM including
non-skeletal tissues (Wagener et al. 2005).
Matrilin-3 consists of a single von Willebrand factor
A-like domain (A-domain), four epidermal growth factor
(EGF)-like motifs and a coiled-coil oligomerization
domain (Wagener et al. 1997). All of the MED-causing
mutations in MATN3 are found in the single A-domain of
matrilin-3 in either the β-strand or α-helix regions
( F r e s q u e te ta l .2008; Jackson et al. 2004). The majority
of these mutations have been shown to result in the
retention of mutant protein in vitro, whereas a smaller
proportion of mutations appear to allow the secretion of
mutant protein (Cotterill et al. 2005;F r e s q u e te ta l .2008).
In order to determine the precise disease mechanisms
that underpin the pathophysiology of MED in vivo, we
generated a murine model by introducing a disease-
causing Matn3 mutation (p.V194D). This mouse model
exhibited significant short-limb dwarfism with a marked
reduction in chondrocyte proliferation and dysregulated
apoptosis within the cartilage growth plates of the
developing limbs. Mutant matrilin-3 was retained within
the rER of chondrocytes, and preliminary experiments
demonstrated the upregulation of BiP and Grp94 in
chondrocytes from 4-day-old mice (Leighton et al. 2007).
The aim of this current study was to use microarray,
quantitative real-time reverse-transcriptase polymerase
chain reaction (qRT-PCR) and Western blotting to com-
prehensively characterise the initial cellular response in
the post-natal stage of the disease.
Materials and methods
Real-time PCR and Western blot analysis
For qRT-PCR, the rib cages from 5-day-old mice (wild type
(wt) and mutant (m/m)) were dissected and treated with
collagenase (type 1A, 2 mg/ml) for 1 h at 37°C in
Dulbecco’s modified Eagle’s medium (DMEM). The costal
cartilage was dissected from individual ribs, and the
perichondrium layer was removed. The cartilage was
digested a second time with collagenase for 3 h to remove
the collagen matrix and release the chondrocytes. The
chondrocytes were passed through a cell strainer (70 μm)
and washed with DMEM containing 10% FBS and
following centrifugation washed again with PBS. The cell
pellet was resuspended in 500 μl TriZol (Invitrogen), and
total RNA was isolated according to the manufacturer’s
instructions. First-strand cDNA was synthesised using
random hexamer primers (Superscript III, Invitrogen), and
qPCR was performed using the SYBR® green PCR
protocol. Primer sequences were: BiP: 5′-ggcaccttc
gatgtgtctcttc-3′ and rev: 5′-tccatgacc cgctgatcaa-3′; Grp94:
5′-taagctgtatgtacgccgcgt-3′ and rev: 5′-ggagatcatcggaatcca-
caac-3′; Calnexin: 5′-tga ttt cct ctc cct ccc ctt-3′ and rev: 5′-
cac tgg aac ctg ttg atg gtg a-3′; Calreticulin: 5′-gct acg tga
agc tgt ttc cga-3′ and rev: 5′-aca tga acc ttc ttg gtg cca g-3’;
Erp72: 5′-agt atg agc cca ggt tcc acg t-3′ and rev: 5′-aga agt
ctt acg atg gcc cac c-3′. Each experiment included ‘no
template’ controls, was run in duplicate and had an 18S
RNA control. Each independent experiment was repeated
three times, and the results were analysed by independent-
samples t test.
For Western blot analysis, chondrocytes were isolated
as above, but aliquots of 2 × 10
5 chondrocytes were
prepared and resuspended in 5× sodium dodecyl sulphate
(SDS) loading buffer containing DTT. These protein
aliquots were separated by 4–12% SDS-polyacrylamide
gel electrophoresis (PAGE; Invitrogen) then transferred to
nitrocellulose membranes for Western blot analysis.
Ponceau staining was used to confirm equal loading of
total protein isolates.
Antibodies to key chaperones associated with the
unfolded protein response were used at a dilution of
either 1:500 (BiP, Grp94, Erp72 and PDI; all from Santa
Cruz) or 1:100 (ATF-6 from Imgenex and Bcl-2 from
Abcam).
836 S. Nundlall et al.Histology and immunohistochemistry
Tissue samples were fixed overnight in ice-cold 10% formalin
(haematoxylin and eosin (H&E) staining and Terminal
deoxynucleotidyl transferase dUTP nick-end labelling
(TUNEL)) or 95% ethanol and 5% acetic acid (immunohisto-
chemistry (IHC) and bromodeoxyuridine (BrdU)). Samples
were then decalcified in 20% EDTA and embedded in paraffin
waxasdescribedpreviously(Leightonetal.2007). Antibodies
used were rabbit anti-matrilin-3 (R&D), rat anti-BrdU
(Abcam) and goat anti-Grp94 (Santa Cruz). Briefly, endog-
enous peroxidase activity was quenched by a H2O2/methanol
wash, followed by hyaluronidase treatment. Samples were
blocked with goat serum (for anti-matrilin-3 and anti-BrdU)
or rabbit serum (for anti-Grp94) and bovine serum albumin
(BSA) in phosphate-buffered saline (PBS) for 1 h and
incubated for 1 h with the primary antibody (in PBS/BSA).
They were then incubated for 1 h with the relevant secondary
antibodies such as biotinylated goat anti-rabbit IgG (Dako
Cytomation), biotinylated goat anti-rat (Abcam) or rabbit
anti-goat (Santa Cruz) in PBS/BSA with goat/rabbit serum.
Slides were then incubated with the ABC complex/HRP
reagent for 30 min and developed using DAB. Samples were
counterstained with methyl green and mounted with Vecta-
Mount. BrdU IHC was performed as above, except the
hyaluronidase step was replaced with an antigen retrieval step
(i.e. incubated in 4 M HCl for 15 min and then neutralised
with 0.1 M borate buffer).
Analysisofapoptosiswasperformedusingthe DeadEnd™
fluorometric TUNEL system (Promega) and visualised with a
Zeiss Axiovision microscope. Nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI) while apoptotic cells
were stained with fluorescein isothiocyanate (FITC). Nested
analysis of variance (ANOVA) was used to assess statistical
significance between treated and untreated samples. A value
of p<0.05 was considered statistically significant.
BrdU labelling of proliferating cells
Twenty-one-day-old mice were injected peritoneally with
0.1 ml of cell proliferation labelling reagent (Amersham) per
10 g of weight and sacrificed after 2 h. The dissected tibias
were fixed and analysed by IHC using an anti-BrdU antibody
(1:100; Abcam). The number of BrdU-labelled cells was
expressed as a proportion ofthe total population ofcells in the
proliferative zone. Nested ANOVA was used to assess
statistical significance between treated and untreated samples.
Ava lu eofp<0.05 was considered statistically significant.
Ultrastructural analysis of cartilage
Ribs from 7-day-old mice were dissected and fixed overnight
in 4% PFA/2.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer followed by three washes in 0.1 M sodium cacodylate
buffer. Samples were then incubated in a secondary fix of 3%
potassium ferrocyanide buffer with 2% osmium oxide for 2 h.
They were washed in distilled water and incubated overnight
for 2 h in 0.5% uranyl acetate at 40°C. The samples were
washed in distilled water and dehydrated in increasing
concentrationsofacetone:50%,70%,90% and100%acetone
for 30 min. The acetone was replaced with two changes of
propylene oxide, which in turn was replaced with Spurr’s
resin. After several changes, the resin was polymerised by
incubatingat60°Cfor 48h.Seventy-nanometer sectionswere
cut and stained with 0.3% (w/v) lead citrate, and images were
taken on a FEI Tecnai 12 Biotwin electron microscope,
recorded on 4489 film (Kodak) and scanned using an
Imacon Flextight 848 scanner (Precision Camera & Video).
Phenotypic analysis of the skeleton
Mice at 63 days of age were sacrificed, and bone length
measurements were made from whole-body radiographs. At
least 20 mice were measured for both treated and control
groups, and nested ANOVA was used to assess statistical
significance between these two groups. A value of p<0.05
was considered statistically significant.
Microarray hybridisation
RNA quality was checked using the RNA 6000 Nano Assay
and analysed on an Agilent 2100 Bioanalyser (Agilent
Technologies). RNA concentration was quantified using a
Nanodrop ultra-low-volume spectrophotometer (Nanodrop
Technologies). The hybridisation cocktail was hybridised to
Mouse 430_2 oligonucleotide arrays (Affymetrix) according
to the manufacturers’ instructions. Arrays were read using an
Agilent GeneArray scanner 3000 7G and processed using
Affymetrix GCOS (V1.4) software. Statistical analysis was
performed using PUMA an R/Bioconductor package for
Propagating Uncertainty in Microarray Analysis (http://
www.bioinf.manchester.ac.uk/resources/puma/index.html).
PPLR is an R package that detects differential gene
expression by including probe-level measurement error and
calculating the probability of positive log-ratio (PPLR). A
PPLR value of 1 indicates significant upregulation whilst
PPLR values closer to 0.5 are not significant.
Blood collection and analysis of SPB
Whole blood was extracted from mice and pooled into 15-ml
fractions, and plasma was isolated by centrifugation. Proteins
were precipitated as described elsewhere (Carducci et al.
2001), and the samples were subjected to reverse-phase high-
performance liquid chromatography (HPLC) on a reverse-
phase C18 synergi 4U hydro 80A column (Phenomenex) as
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phenylbutyrate (SPB; special diet services, SCANBUR) and
control compounds (phenylacetate and phenylacetylglutamine)
were checked for purity by liquid chromatography time of
flight mass spectrometry. Control samples were diluted in a
range of 10–20 pmol/l for the generation of standard curves.
Cell culture and transfection
Chinese hamster ovary-B2 (CHO) cells were cultured in
Ham’s F-12 media supplemented with 10% FBS, 2 mM
L-glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin. Human wt matrilin-3 A-domain and the Ile192Asn
mutation had previously been sub-cloned into pSecTag2A
in-frame to a C-terminal c-myc epitope tag and transfected
into CHO cells (Cotterill et al. 2005).
SPB treatment of CHO cell cultures
Transfected CHO cells were seeded into 75-cm
2 vented
flasks at a density of ∼1.5 × 10
6 cells per flask. CHO cells
were cultured in SPB (Biomol International, Exeter, UK)
administered directly into the culture media at final
concentrations of 0 mM (untreated), 0.1, 0.5, 1, 5 and
10 mM. Cells were treated with SPB until confluent at
which time protein samples were prepared for SDS-PAGE.
Sample preparation for SDS-PAGE and Western blotting
Conditioned media was removed, and the cells were lysed
for SDS-PAGE and Western blot analysis. To ensure that
equal quantities of protein were analysed, untreated and
SPB-treated cells were counted using a haemocytometer
and equal numbers of cells were resuspended in 1 ml of
culture media as appropriate. Media and lysate protein
samples were analysed by SDS-PAGE and Western blotting
as described previously (Cotterill et al. 2005).
Results
In order to obtain sufficient quantities of cartilage for qRT-
PCR and Western blotting studies, we decided to use rib
and xiphoid cartilage, which are amenable to accurate and
reproducible dissection. Therefore, in the first instance, we
demonstrated that rib and xiphoid cartilage had a tissue
pathology that was comparable to the tibia growth plate.
The cartilage growth plate in ribs and xiphoid
is disorganised in mice harbouring the Matn3 mutation
H&E staining was performed on tissue sections in order to
characterise the differences in growth plate morphology in the
mutant mice compared to wild-type controls (Fig. 1a, b). The
growth plates of both the rib and xiphoid cartilage from wt
mice were well-organised at 5 and 21 days of age as
expected. For example, the demarcation of the individual
zones of the growth plate was clearly distinguishable, and
chondrocytes in the proliferative zone were arranged in an
ordered columnar organisation along the vertical axis of the
growth plate (Fig. 1a, b; black boxes in left panels).
However, in the growth plates from mice homozygous for
the mutation (m/m), the columnar organisation of the
chondrocytes within the proliferative zone was disrupted
from 5 days of age, and the chondrocytes, instead of forming
ordered columns, were more randomly arranged and
generally disorganised (Fig. 1a, b; red circles in right panels).
These observations were consistent with the tibia growth
plate as described previously (Leighton et al. 2007).
Mutant matrilin-3 is retained within the chondrocytes
of both rib and xiphoid cartilage
IHC staining of wild-type (wt) xiphoid and rib cartilage
with an anti-matrilin-3 antibody confirmed that matrilin-3
was found exclusively within the ECM of the growth plate
as expected (Fig. 1c, d). In contrast, IHC analysis of
cartilage from mice homozygous for the mutation demon-
strated that the majority of matrilin-3 was retained within
the chondrocytes and that there was only minimal staining
in the ECM. This retention, which was observed in
chondrocytes from all regions of the growth plate, is
evident by 5 days of age and still present at 21 days of
age. These findings were again consistent with the tibia
growth plate as described previously (Leighton et al. 2007).
Ultrastructural analysis of cartilage showed enlarged
individual cisternae of rER within rib chondrocytes
from mutant mice
The ultrastructure of rib cartilage from 7-day-old mice was
studied by transmission electron microscopy (TEM; Fig. 2
and data not shown). The resting chondrocytes in the growth
plates of wild-type mice were evenly distributed and
Fig. 1 Histological and immunohistochemical analysis of wild-type
and mutant xiphoid and rib cartilage. H&E staining of wild-type
(wt) and mutant (m/m) a rib and b xiphoid cartilage growth plates
from 5- and 21-day-old mice. Cells in the proliferativezone form ordered
columnsalongthe vertical axis of the GP (black boxes). In the m/m mice
by 5 days of age, the chondrocytes (red circles) of the proliferative zone
are rounder and more randomly orientated compared to the wt (black
box). Scale bar is 100 µm. IHC with an anti-matrilin-3 antibody on c rib
and d xiphoid growth plates from 5-, 14- and 21-day-old mice. In wild-
type mice (wt), matrilin-3 staining was seen in the cartilage ECM at all
ages. In mutant mice (m/m), matrilin-3 staining was predominantly
within the chondrocytes with only minimal staining present in the ECM.
Intracellular staining was observed from 5 days of age and was still
present by 21 days of age

838 S. Nundlall et al.contained organised and folded cisternae of rER that
appeared within normal limits (i.e. contained a limited
amount of protein material that would be expected in
chondrocytes actively synthesising and secreting ECM
components). However, in the chondrocytes of cartilage
from mutant mice, there were numerous dilated cisternae of
rER that contained large amounts of amorphous material and
which was confirmatory of retained protein (Fig. 2). Dilated
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cartilage, and very few normal cisternae were present.
In the wild-type growth plate, the proliferative cells were
flatter than resting chondrocytes and formed well-organised
and tightly stacked two-, four- and eight-cell chondrons.
However, in cartilage from mutant mice, the proliferative
cells were generally slightly enlarged due to their dilated
cisternae, which affected the spatial organisation of indi-
vidual cells within the chondrons since they were unable to
align as closely (data not shown).
The hypertrophic chondrocytes in the wild-type growth
plates were generally rectangular in shape, and the
condensed chromatin was clearly visible. However, in
mutant mice, the hypertrophic cells were more irregular in
shape, and there were clear remnants of intracellular protein
(Fig. 2).
Overall, these pathological findings were consistent with
those seen in the tibia growth plate as described previously
(Leighton et al. 2007) and validated the use of rib and
xiphoid cartilage for gene and protein expression studies.
However, in characterising these tissues, we noted that after
approximately 7 days of age the central part of the ribs
began to ossify, which significantly reduced the number of
chondrocytes that could be isolated. We therefore decided
to use rib cartilage for the 5-day study and xiphoid cartilage
for the 21-day study.
Gene expression profiling shows a significant activation
of the UPR in mutant chondrocytes at 5 days of age
that is still maintained at 21 days of age
In order to determine the differential gene expression
caused by the Matn3 V194D mutation, we chose to perform
an Affymetrix genechip microarray hybridisation using
RNA isolated from 5-day-old rib chondrocytes. We chose
to concentrate on the 20 most significantly upregulated
genes that were directly related to ER stress, UPR and/or
protein folding, and these are summarised in Table 1.
In order to validate some of these microarray data, we
performed qRT-PCR and Western blot analysis on a selection
of genes (Fig. 3). Real-time PCR analysis confirmed a
significant ∼2.4-fold increase in BiP and a ∼4.5-fold increase
in Grp94. In addition, ERp72, calnexin (canx) and calreticu-
lin (calr) were also significantly upregulated by ∼2.7-, ∼2.8-
and ∼2.8-fold, respectively (Fig. 3a). To verify the protein
levels of individual chaperones, Western blots were per-
formed for Grp94, BiP, ERp72 and PDI, and these were
found to have significant fold increases of ∼1.5, ∼1.4, ∼2.6
and ∼1.3, respectively (Fig. 3b, c). A summary of the gene
and protein expression levels for the upregulated chaperones
is presented in Fig. 3d. Overall, these data confirm a
significant activation of the UPR in the chondrocytes of 5-
day-old mice homozygous for the Matn3 V194D mutation.
We also investigated the UPR in chondrocytes from the
xiphoid cartilage of wild-type and mutant mice at 21 days
of age. Western blots showed that there was still an
increased level of ER stress in mutant chondrocytes
compared to wild type. For example, BiP was upregulated
by ∼1.3-fold, ERp72 by ∼1.7-fold and Grp94 by ∼3-fold
(Fig. 4a). Furthermore, IHC staining performed using an
anti-Grp94 antibody showed stronger staining in the
xiphoid growth plate from 21-day-old mutant mice
(Fig. 4b).
Fig. 2 Ultrastructural analysis of 7-day-old rib cartilage using TEM
shows enlarged rER cisternae in mutant chondrocytes. Mutant chondro-
cytes in the resting (asterisk) and proliferative (arrow) zones of the
growth plate have dilated cisternae of rER compared to wild-type
chondrocytes from the same regions. Mutant hypertrophic chondrocytes
contain the remnants of intracellular protein (arrowhead) which is not
seen in wild-type hypertrophic chondrocytes
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chondrocytes at 5 days of age, we also examined the
downstream mediators of the ER stress response, which
included the cleavage of the ER membrane-anchored
transcription factor ATF6 and the activation by splicing
of transcription factor X-bp1. Both of these factors have
been shown to be activated in a mouse model of
PSACH-MED caused by a Comp mutation (Pirog-Garcia
et al. 2007) and the former in a mouse model of MCDS
c a u s e db yam u t a t i o ni ncol10a1 (Rajpar et al. 2009). We
saw no evidence of the cleavage of ATF6 in either the
wild-type or mutant chondrocyte protein extractions,
compared to a positive control from the MCDS mouse
(Supplemental Fig. S1). Furthermore, there were no dif-
ferences between the splicing of X-bp1 mRNA in either
wild-type or mutant chondrocytes.
ER stress does not lead to increased chondrocyte apoptosis
in rib cartilage at 5 days of age
We have previously reported that there is dysregulated
chondrocyte apoptosis at 3 weeks of age in the tibia
growth plates of mice homozygous for the mutation
(Leighton et al. 2007). We therefore wished to determine
the pathological effect of ER stress and the UPR on
chondrocyte viability at 5 days of age. TUNEL assays
were performed to quantify the relative levels of chon-
drocyte apoptosis in the growth plates of ribs from wild-
type and mutant mice; however, there were no significant
differences in the relative numbers, or position, of
TUNEL-positive cells between the different genotypes.
Approximately 1.96% of cells were TUNEL positive in
the hypertrophic zone of growth plates from wild type
mice, whilst 1.98% of cells were TUNEL positive in the
hypertrophic zone of mutant mice, but this small increase
in apoptosis was not statistically significant (Fig. 5a).
Furthermore, the expression of CHOP, an ER-stress-
mediated pro-apoptotic factor, was slightly but signifi-
cantly downregulated in mutant cells at 5 (rib) and 21
(xiphoid) days of age as determined by qRT-PCR
(Fig. 5b). Finally, there was no change in the anti-
apoptotic factor Bcl2 in mutant chondrocytes from ribs at
5 days of age as measured by densitometry of Western
blots (Fig. 5c).
Table 1 A microarray hybridisation was performed on RNA isolated from the chondrocytes of 5-day-old rib cartilage from wild-type and mutant
mice
Gene and/or protein name Gene symbol NCBI mouse gene ID Fold change (mut vs. wt)
Cysteine-rich with EGF-like domains 2 Creld2 76737 5.77
Heat shock protein 90 kDa beta (Grp94), member 1 Grp94/Hsp90b1 22027 4.59
Transformation-related protein 53 binding protein 1 Trp53bp1 27223 4.58
Arginine-rich, mutated in early stage tumours Armet 315989 4.29
Protein disulfide isomerase-associated 6 Pdia6 71853 3.18
Protein disulfide isomerase-associated 4 (Erp72) Erp72/Pdia4 12304 3.16
DnaJ (Hsp40) homologue, subfamily A, member 4 Dnaja4 58233 3.06
Solute carrier family 35, member B1 Slc35b1 110172 2.61
Serine (or cysteine) peptidase inhibitor, clade A, member 3 N Serpina3n 20716 2.29
Mannoside acetylglucosaminyltransferase 2 Mgat2 217664 2.11
DnaJ (Hsp40) homolog, subfamily C, member 3 Dnajc3 100037258 2.57
Signal peptidase complex subunit 3 homolog (S. cerevisiae) Spcs3 317409 2.50
Heat shock 70 kDa protein 5 (glucose-regulated protein BiP) BiP/Hspa5 14828 2.46
Signal peptidase complex subunit 2 homolog (S. cerevisiae) Spcs2 66624 2.16
DnaJ (Hsp40) homologue, subfamily B, member 1 Dnajb1 81489 2.10
Calnexin Canx 12330 2.10
Protein disulfide isomerase-associated 3 (Erp 57) Erp57/Pdia3 14827 2.03
Calreticulin Calr 12317 1.95
Homocysteine-inducible, endoplasmic reticulum stress-inducible,
ubiquitin-like domain member 1
Herpud1 64209 1.83
Nucleobindin 1 Nucb1 18220 1.82
The relative expression levels of the 20 most upregulated genes with a relevant significance (PPLR) value of 1 are shown. PPLR is an R package
that detects differential gene expression by including probe-level measurement error and calculating the probability of positive log-ratio (PPLR).
A PPLR value of 1 indicates significant upregulation whilst PPLR values closer to 0.5 are not significant. The gene/protein name is the one
recorded by the Affymetrix microarray software, and the NCBI geneID has been included as a reference. Note that PDI itself is not represented on
the microarray chip but that the other family members Pdia2-6 are present
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phenylbutyrate as an aid to alleviate the phenotype
Mutant mice were fed standard mouse chow pellets
supplemented with SPB at a concentration of 7 g/kg diet
(effective daily consumption ∼1 g SPB/kg body weight) in
an attempt to aid the folding and secretion of mutant
matrilin-3 and alleviate the ER stress/UPR. Untreated mice
were fed with food without SPB. Quantification of blood
plasma showed the presence of SPB at a concentration of
100 μmol/l. Furthermore, SPB was detected in the
stomachs of mice whose diet consisted of milk from their
mothers who themselves were on the SPB diet (data not
shown).
Microarray hybridisation was performed using RNA
isolated from rib chondrocytes of 5-day-old mutant mice to
Fig. 3 qRT-PCR and Western blot validation of ER stress and UPR
markers in chondrocytes from 5-day-old mutant mice. a qRT-PCR was
used to validate the relative levels of gene expression in mutant (m/m)
chondrocytes compared to wild-type (wt) chondrocytes. In all cases, the
levels of mRNA was normalised against 18S RNA. The relative levels
of BiP, Grp94, ERp72, calnexin (Canx) and calreticulin (Calr) mRNA
were increased between ∼2-fold and ∼4-fold in mutant chondrocytes
[n=3 litters per genotype (approximately five to ten mice per litter) and
three separate experiments were performed in duplicate; independent t
test *p<0.05 or **p<0.01)]. b Total cellular protein was isolated from
aliquots of 2×10
5 wt and m/m chondrocytes and analysed by SDS-
PAGE and Western blotting using antibodies against Grp94 (∼94 kDa),
BiP (∼76 kDa), ERp72 (∼72 kDa) and PDI (∼58 kDa). Western blotting
consistently showed that the levels of these four proteins were increased
in m/m samples compared to wt. [n=3 litters per genotype (∼5–10 mice
per litter) and three separate experiments were performed in duplicate;
independent t test *p<0.05 or **p<0.01)]. c The Western blots were
scanned and analysed by densitometry, which showed that there was a
1.5-fold increase in Grp94, 1.4-fold increase in BiP, 2.6-fold increase in
ERp72 and a ∼1.3-fold increase in PDI. d Comparison of the relative
expression levels determined by microarray, qRT-PCR and Western
blotting all showed an upregulation of key molecular chaperones
842 S. Nundlall et al.characterise the changes in gene expression following
treatment with SPB (i.e. treated mutant mice vs. untreated
mutant mice). The expression levels of the major chaper-
ones BiP, Grp94, calnexin, ERp72, calreticulin and ERp57
were unchanged in treated mice compared to untreated
mice (Table 2). However, at 21 days of age, the protein
levels of the chaperones BiP, Grp94 and Erp72 were
slightly, but significantly, downregulated by ∼0.74-fold,
∼0.69-fold and ∼0.79-fold, respectively, in the xiphoid
chondrocytes of the treated mice (Fig. 6).
Nevertheless, SPB treatment did not improve the pheno-
type of the mutant mice as determined by body weights and
bone length measurements of 21-day-old mice, which
were indistinguishable between untreated and treated
mice (Fig. 7a, b). Interestingly, TUNEL assays performed
on 3-week-old tibia growth plates showed that 0.51% of
cells in the hypertrophic zone were TUNEL positive in the
sections from SPB-treated mutant mice compared to
0.62% in the sections from untreated mice, which equates
to a 17% decrease in apoptosis (Fig. 7c). The relative
levels of TUNEL-positive chondrocytes at the vascular
invasion front (VIF) were 1.4% in the sections from
SPB-treated mice compared to 1.1% in untreated mice
(Fig. 7d). Furthermore, there was an increase in chon-
drocyte proliferation in the proliferative zone of growth
plates from SPB-treated mice as determined by BrdU
labelling. Within the proliferation zone of SPB-treated
mice, 12.3% of cell nuclei were labelled with BrdU, whilst
in the same region of the untreated samples only 11.4% of
cell nuclei were labelled, thus representing an 8% increase
in chondrocyte proliferation (Fig. 7e). However, the
differences in both apoptosis and cell proliferation were
not found to be statistically significant using nested
ANOVA analysis. We performed similar studies with a
mouse model of Schmid metaphyseal chondrodysplasia
(Rajpar et al. 2009), but again this treatment did not
improve the phenotype (Supplemental Fig. S2).
Finally, to determine whether treatment with SPB aids
the secretion of mutant protein into the ECM, we used IHC
staining on fixed sections from 3-week-old tibia growth
plates. However, there was no apparent improvement in the
secretion of mutant matrilin-3 in SPB-treated mice since
matrilin-3 staining was indistinguishable in tibia growth
plates from treated and untreated mutant mice (Fig. 7e).
We wished to determine if SPB could aid in the secretion
of mutant protein from a cell culture model of mutant
matrilin-3 A-domains that we have previously characterised
(Cotterill et al. 2005; Fresquet et al. 2008). Increasing
concentrations of SPB (0.1 to 10 mM) failed to aid the
secretion of the mutant matrilin-3 A-domain (Supplemental
Fig. S3); however, we did notice that the addition of SPB
up to a final concentration of 5 mM increased the
expression of both wild-type and mutant proteins. The
addition of 10 mM SPB reduced the yields of recombinant
protein, although they were still higher than without the
addition of SPB (Supplemental Fig. S3) and also had a
detrimental effect on cell viability regardless of whether
the cells were expressing mutant or wild type matrilin-3
A-domains (not shown).
Discussion
The aim of this study was to characterise the initial cellular
response to the expression of mutant matrilin-3 with the
intention of identifying the key genetic pathway(s) that are
ultimately responsible for decreased chondrocyte prolifera-
tion and dysregulated apoptosis at 3 weeks of age (Leighton
Fig. 4 The UPR is maintained
at 21 days of age in mutant
chondrocytes from xiphoid
cartilage. a Western blot densi-
tometry shows an upregulation
of chaperones in chondrocytes
from the xiphoid cartilage of
21-day-old mutant mice. Erp72
was upregulated by ∼1.8-fold,
Grp94 by ∼3-fold and BiP
by ∼1.3-fold, respectively. [n=3
mice per genotype and three
separate experiments were
performed in triplicate, indepen-
dent t test *p<0.05]. b IHC
staining performed using an anti-
Grp94 antibody showed stronger
staining in the xiphoid growth
plate from 21-day-old mutant
mice, particularly in chondro-
cytes from the proliferative zone
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that a UPR is rapidly activated in the post-natal period,
which is most likely due to accumulation of misfolded
matrilin-3 within the rER of growth plate chondrocytes.
We initially demonstrated that rib and xiphoid cartilage
from mutant animals displayed a tissue pathology that was
similar to that previously reported for the growth plates of
the major long bones (i.e. femur and tibia; Leighton et al.
2007). This disease pathology is characterised by the
intracellular retention of mutant matrilin-3 from birth and
a generalised growth plate dysplasia characterised by
abnormal chondrocyte morphology and their misalignment
within the proliferative zone. This observation suggests that
weight bearing is not a factor in the expression and
intracellular retention of mutant matrilin-3, which is
consistent with similar findings in a pseudoachondroplastic
Scottish deerhound (Stevens 1999). Our findings therefore
confirm that MED is a generalised cartilage disorder
(chondrodysplasia), which manifests itself most profoundly
in the growth of the long bones.
The UPR that is activated in mutant chondrocytes in
vivo is characterised by the upregulation of key chaperones
that are known to be associated with ER stress responses or
protein folding and quality control. These include BiP
Fig. 5 TUNEL assay, CHOP and Bcl-2 analysis in chondrocytes of
cartilage from wild-type and mutant mice at 5 (rib) and 21 (xiphoid)
days of age. a End-stage apoptosis (DNA fragmentation) was
measured in the ribs of 5-day-old mice using TUNEL assay. The
relative levels of apoptosis were calculated by comparing the number
of apoptotic chondrocytes (FITC-labelled nuclei) with the total
number of chondrocytes in the hypertrophic zone (DAPI-labelled
nuclei+FITC-labelled nuclei). TUNEL assay showed that there were
no differences in the relative levels of apoptosis between mutant and
wild-type chondrocytes from 5-day-old mice [n > 20 sections per
genotype, independent t test]. b Chondrocytes were isolated from the
ribs of 5-day-old mice and the xiphoid of 21-day-old mice, and the
RNA was extracted. The relative levels of CHOP mRNA in mutant
chondrocytes compared to wt chondrocytes are shown at 5 and
21 days of age. The mRNA levels were normalised against 18S RNA.
There was a modest, but significant, reduction in CHOP mRNA in
mutant chondrocytes. [n=3 litters per genotype (five to ten mice per
litter) and three separate experiments were performed in duplicate,
independent t test *p<0.05]. c Total cellular protein from 5-day-old
rib cartilage was analysed by SDS-PAGE and Western blotting with
anti-Bcl2. Representative Western blots show similar levels of Bcl-2
protein in mutant cells compared to wild type. Densitometry
confirmed that there was no statistically significant difference in
Bcl-2 levels between wild type and mutant. [n=3 mice per genotype
(five to ten mice per litter) and three separate experiments performed
in triplicate, independent t test]
844 S. Nundlall et al.(which is a member of the Hsp70 family), Grp94, members
of the Hsp40 protein family (Dnajb1, Dnajc3 and Dnaja4)
and also Pdia3 (ERp57), Pdia4 (ERp72) and Pdia6. The
PDI family of protein disulphide isomerase-associated
proteins (PDIA2-6) are ER resident proteins that catalyse
in turn the formation, reduction and isomerisation of
disulphide-bonded proteins such as matrilin-3 (Hatahet
and Ruddock 2007). PDI can also interact with the lectin
chaperones calreticulin and calnexin, which were also
increased in mutant chondrocytes. Calnexin and calreticulin
bind to and mediate the folding of newly synthesised
glycoproteins and are important in monitoring the N-linked
glycans that persist on unfolded or misfolded glycoproteins.
The increased expression of these two genes in mutant
chondrocytes might be expected since matrilin-3 has a
potential N-linked glycosylation site (Wagener et al. 1997).
The upregulation of Mgat2 is further evidence that mutant
matrilin-3 is being recognised and processed by the Canx/
Calr folding pathway. Mgat2 encodes a Golgi enzyme called
monoacylglycerol acyltransferase 2, which catalyses an
essential step in the conversion of oligomannose to complex
N-glycans, and mice deficient in Mgat2 have a congenital
disorder of glycosylation type IIa (Wang et al. 2002).
Furthermore, patients with the autosomal recessive disease
carbohydrate-deficient glycoprotein syndrome type II have
been shown to have mutations in MGAT2 (Tan et al. 1996).
We have previously shown in a cell culture model
(Cotterill et al. 2005) that mutant matrilin-3 A-domains
are predominantly unfolded in the rER of cells and are
directly associated with ERp72 (Pdia4), a member of the
protein disulphide isomerase family. This is consistent
with the ∼3-fold increase in the expression of Pdia4 in
mutant mouse chondrocytes (Table 1). Interestingly, in the
cell culture system, no direct association was seen with
PDI, BiP or Grp94, and this disparity in the chaperone
protein profile between the in vitro and in vivo studies is
most likely due to differences in the recognition and
processing of full-length mutant matrilin-3 (this study)
compared to the mutant A-domain alone (Cotterill et al.
2005). For example, the potential N-linked glycosylation site
of matrilin-3 is in the second EGF-like domain between
residues (Asn
321–Gly
322–Ser
323) and not the A-domain
(Wagener et al. 1997).
In addition to chaperone/heat shock proteins and members
of the lectin/PDI folding complexes, we also identified genes
by the microarray studies that are known to play a role in
ER-associated degradation such as homocysteine-inducible,
endoplasmic-reticulum-stress-inducible, ubiquitin-like do-
main member 1 (Herpud1; Kim et al. 2008), suggesting that
some misfolded matrilin-3 might be targeted for degradation.
Table 2 Microarray hybridisations were performed on RNA isolated from rib chondrocytes of 5-day-old treated and untreated mutant mice
Chaperone Expression fold change
(treated vs untreated)
Significance value
(PPLR)
Expression levels (microarray)
Control Treated
BiP 1.01 0.52 6,346.856 6,437.842
Grp94 1.08 0.32 39.194238 36.16048094
Erp72 (Pdia4) 1.04 0.434 716.4064 688.284
Calreticulin 1.00 0.512 3,529.2909 3,550.645517
Erp 57 (Pdia3) 1.06 0.329 5,520.895 5,173.721
Calnexin 1.05 0.659 3,312.7712 3,489.222069
There were no changes in the expression levels of key chaperone genes. N=3 litters (of eight to ten mice per litter) per sample (treated and
untreated) mutant mice and three separate experiments were performed in duplicate. A significance (PPLR) value of 1 indicates significant
upregulation whilst PPLR values closer to 0.5 are not significant
Fig. 6 Chaperone protein levels are reduced in treated mice at
3 weeks of age. Densitometry of Western blots of chondrocyte total
protein from xiphoid cartilage of 21-day-old treated and untreated
mutant mice. The chaperone protein levels at 21 days of age are
slightly, but significantly, downregulated in the chondrocytes from
the treated mutant mice. There was a ∼0.79-fold decrease in Erp72,
∼0.74-fold decrease in Grp78 and a ∼0.69-fold decrease in Grp94.
[n=3 mice per group (treated and untreated) and two pooled
cartilage samples were used in three separate experiments performed
in triplicate; independent t test *p<0.05]
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upregulated in mutant chondrocytes were several genes
that have only recently been implicated in ER stress. For
example, cysteine-rich with EGF-like domains 2 (Creld2),
which was the most highly upregulated gene in mutant
chondrocytes has recently been reported as a novel ER-
stress-inducible gene (Oh-hashi et al. 2009). The promoter
region of Creld2 contains a typical ER-stress-responsible
element (ERSE) and, whilst it is believed to be involved in
the folding and transport of proteins through the ER and
Golgi, its precise role has yet to be determined (Ortiz et al.
2005). Another gene over-expressed to a similar extent as
Creld2 was arginine-rich, mutated in early stage of tumours
(Armet; also known as MANF), which is known to be
activated by the UPR via an ERSE-II element (Mizobuchi et
al. 2007). Furthermore, over-expression of Armet in cell
culture has been shown to inhibit cell proliferation and ER-
stress-induced apoptosis (Apostolou et al. 2008), both of
which are key features of the growth plate dysplasia in the
MED-Matn3 mouse model (Leighton et al. 2007).
We were able to determine that the post-natal activation of
a UPR in mutant chondrocytes did not result in an immediate
increase and/or dysregulation of CHOP-mediated apoptosis
by 5 days of age. Furthermore, our data suggest that at 5 days
of age the UPR is still primarily BiP-mediated and has not
progressed to other downstream mediators, such as the IRE1
and PERK receptors as shown by a lack of ATF6 cleavage or
X-bp1 splicing. Unfortunately, due to technical constraints, it
846 S. Nundlall et al.was not possible to examine chondrocyte proliferation at this
age since the mice are too small for peritoneal injection. In the
long term, however, determining the precise time of onset of
reduced chondrocyte proliferation and spatially dysregulated
apoptosis in vivo will be important for understanding the
disease process and delineating the influence of these two
pathological components of MED.
We hypothesised that alleviating the rER stress and/or
UPR in mutant chondrocytes may have an impact on cell
phenotype and might lessen or even prevent the reduction
in cell proliferation and increase spatially dysregulated
apoptosis, eventually restoring normal long-bone growth.
SPB is a butyrate analogue that is approved for clinical use
as an ammonia scavenger in subjects with urea cycle
disorders. It is also a known transcriptional regulator that
may act by inhibiting histone deacetylase (Candido et al.
1978). Previous studies have shown that SPB has properties
that aid the trafficking and secretion of mutant proteins in a
variety of protein folding diseases such as cystic fibrosis
(Rubenstein and Zeitlin 2000), hereditary hemochromatosis
(de Almeida et al. 2007) and glaucoma (Tsang et al. 2007)
and has been found to prevent aggregation of proteins in
vitro in neurodegenerative diseases (Ryu et al. 2005).
Finally, oral dosage of SPB improved the phenotype in a
mouse model of type 2 diabetes (Ozcan et al. 2006) that
was linked to ER cell stress (Ozcan et al. 2004).
We used a similar dosage protocol to that of Ozcan et al.
(2006); however, SPB administered at this dosage in the
food did not have an effect on MED disease severity as
determined by body weight and bone length measurements
at 9 weeks of age. Furthermore, there was no significant
improvement in chondrocyte proliferation and apoptosis at
3 weeks of age. Although there appeared to be a modest
increase (∼8%) in chondrocyte proliferation at 3 weeks of
age, this was not statistically significant, which might in
part be due to the natural variability between litters.
Furthermore, at 5 days of age, microarray analysis showed
no changes in the expression levels of chaperones in mutant
chondrocytes following treatment with SPB. Nevertheless,
by 3 weeks of age, there was a modest but significant
decrease in the protein levels of ERp72, BiP and Grp94, but
ultimately this did not affect the trafficking of mutant
matrilin-3, which remained predominately intracellular
regardless of whether the mice were treated with SPB or
not. SPB is known to regulate general transcription due to
its role as a histone deacetylase inhibitor. The microarray
results for [m/m vs. wt] and [treated vs. untreated] had a
similar overall proportion of downregulated genes with
47% of genes downregulated in [m/m vs. wt] and 43% of
genes downregulated in [treated vs. untreated], suggesting
that SPB did not have a major effect on the global
transcription of genes in chondrocytes.
In a parallel study, we also investigated the effect of SPB
treatmentonamousemodelofmetaphysealchondrodysplasia
typeSchmid(MCDS)thatwehaverecentlydescribed (Rajpar
et al. 2009). However, like the Matn3-MED mouse, SPB
treatment failed to improve the disease phenotype.
One possible reason for the SPB treatment having no
effect on mutant matrilin-3 secretion, ER stress, chondro-
cyte proliferation and apoptosis may be due to the avascular
nature of cartilage. There are no blood capillaries within
cartilage, and only the perichondrium is vascularised.
Instead, chondrocytes get their nutrient supply by diffusion
from blood vessels of the perichondrium. Compressive
loading of cartilage creates a pumping action due to the gel-
like and hydrated nature of cartilage that facilitates this
diffusion. Since there is no readily accessible blood supply
to the chondrocytes, this will limit the diffusion of SPB into
the chondrocytes. Therefore, it is possible that SPB takes
time to enter the chondrocytes or may not be reaching them
at all. Targeting of SPB directly into cartilage may help to
overcome this potential problem. However, we were unable
to show that treatment with SPB could aid in the secretion
of mutant matrilin-3 A-domains in vitro. Interestingly,
treatment with SPB up to 5 mM did increase the overall
expression of recombinant protein and may be acting by
reducing the ER stress in cells induced to over-express a
recombinant protein. This finding is outside the scope of
the current study but deserves further investigation.
In summary, MED is caused by a defect in the trafficking
and secretion of mutant matrilin-3 that causes ER stress and a
UPR in the post-natal period. Treatment with SPB may have
an effect on ER stress and UPR at later stages of the disease,
Fig. 7 The effect of SPB treatment on the phenotype of mutant mice
and the relative levels of matrilin-3 retention, chondrocyte prolifera-
tion and apoptosis. a Bone length measurements of treated and
untreated mutant male mice were performed on radiographs taken at
9 weeks of age showed no significant differences. Measurements were
made of the inner canthal distance (ICD), femur (F), pelvis (P) and
tibia (T). (n> 23 mice per group; nested ANOVA). b The body
weights of male and female mutant mice showed no significant
differences between untreated and treated groups. (n> 23 mice; nested
ANOVA). The relative levels of apoptosis in c the hypertrophic zone
(HZ) and d at the VIF of the growth plate was calculated by counting
the number of TUNEL-positive chondrocytes in the HZ or at the VIF
compared to the total number of DAPI-stained chondrocytes in the
growth plate. Although there appeared to be relatively less TUNEL-
positive cells in the HZ and more apoptosis at the VIF in the treated
group, these differences were not statistically significant. (n>2 0
sections per group; nested ANOVA). e Twenty-one-day-old mice were
administered with 0.01 ml/g of the nucleotide analogue BrdU 2 h prior
to sacrifice. IHC was performed on tibia sections using an anti-BrdU
antibody. The relative levels of chondrocyte proliferation was
determined by counting the number of BrdU-labelled nuclei compared
to the total number of chondrocytes in the proliferative zone of the
growth plate. There were no significant differences in the proportion
of proliferating cells between the treated and untreated groups. (n>2 0
sections per group; nested ANOVA). f IHC using anti-matrilin-3
antibody on tibia growth plates from 21-day-old mutant mice either
treated or untreated with SPB. In both groups, there is extensive
intracellular retention of mutant matrilin-3 (scale bar is 100 µm)

Initial cellular response to the expression of mutant matrilin-3 847but it is too late or has insufficient efficacy to influence the
disease phenotype. However, these preliminary studies using
chemical chaperones will hopefully pave the way for
developing suitable therapies for patients with MED and
related diseases.
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